Tonix Pharmaceuticals Announces Agreement to Acquire Infectious Disease R&D Facility to Accelerate Development of Vaccines and Antiviral Drugs
Go back to Tonix Pharmaceuticals Announces Agreement to Acquire Infectious Disease R&D Facility to Accelerate Development of Vaccines and Antiviral Drugs| TONIX PHARM HLDG (NASDAQ: TNXP) | Delayed: 10.72 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.72 | 52 Week High | $7.95 | |||
| Open | $10.72 | 52 Week Low | $0.40 | |||
| Day High | $10.72 | P/E | N/A | |||
| Day Low | $10.72 | EPS | $-5.33 | |||
| Volume | 6,170 | |||||
